CCO Expert Recap

Endocrine

Source: CCO Independent Conference Coverage of the 2007 San Antonio Breast Cancer Symposium*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Early Breast Cancer: Endocrine Therapy

Faculty:

Harold J. Burstein, MD, PhD headshot
  • Harold J. Burstein, MD, PhD

CME CREDIT INFORMATION

Release Date: 02/27/08

Expiration Date: 02/26/09


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Registered Nurses: 0.7 Nursing CE credit

Status: Please log in to view status


Harold J. Burstein, MD, PhD, discusses the most clinically relevant new data on endocrine therapy for early breast cancer from the 2007 San Antonio Breast Cancer Symposium.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Summarize the results of recent studies of adjuvant and neoadjuvant chemotherapy for the treatment of breast cancer
  • Discuss therapies designed to preserve the musculoskeletal health for women on hormonal therapy
  • Describe how CYP2D6 polymorphisms may affect the efficacy of tamoxifen in women with estrogen receptor–positive breast cancer

Slideset

Early Breast Cancer: Endocrine Therapy


Harold J. Burstein, MD, PhD, discusses the most clinically relevant data from the 2007 San Antonio Breast Cancer Symposium.


Format: Microsoft PowerPoint (.ppt) | File size: 505 KB